Works by Dahlman, Kimberly B.

Results: 10
    1

    Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma.

    Published in:
    Cancers, 2021, v. 13, n. 6, p. 1475, doi. 10.3390/cancers13061475
    By:
    • Shiuan, Eileen;
    • Reddy, Anupama;
    • Dudzinski, Stephanie O.;
    • Lim, Aaron R.;
    • Sugiura, Ayaka;
    • Hongo, Rachel;
    • Young, Kirsten;
    • Liu, Xian-De;
    • Smith, Christof C.;
    • O'Neal, Jamye;
    • Dahlman, Kimberly B.;
    • McAlister, Renee;
    • Chen, Beiru;
    • Ruma, Kristen;
    • Roscoe, Nathan;
    • Bender, Jehovana;
    • Ward, Joolz;
    • Kim, Ju Young;
    • Vaupel, Christine;
    • Bordeaux, Jennifer
    Publication type:
    Article
    2
    3
    4
    5
    6

    Safety and Efficacy of Avelumab in Small Bowel Adenocarcinoma.

    Published in:
    2022
    By:
    • Cardin, Dana B.;
    • Gilbert, Jill;
    • Whisenant, Jennifer G.;
    • Ayers, Gregory D.;
    • Jalikis, Florencia;
    • Dahlman, Kimberly B.;
    • O'Neal, Jamye F.;
    • Revetta, Frank;
    • Chanjuan Shi;
    • Berlinl, Jordan;
    • Shi, Chanjuan;
    • Berlin, Jordan
    Publication type:
    journal article
    7

    RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E).

    Published in:
    Nature, 2011, v. 480, n. 7377, p. 387, doi. 10.1038/nature10662
    By:
    • Poulikakos, Poulikos I.;
    • Persaud, Yogindra;
    • Janakiraman, Manickam;
    • Kong, Xiangju;
    • Ng, Charles;
    • Moriceau, Gatien;
    • Shi, Hubing;
    • Atefi, Mohammad;
    • Titz, Bjoern;
    • Gabay, May Tal;
    • Salton, Maayan;
    • Dahlman, Kimberly B.;
    • Tadi, Madhavi;
    • Wargo, Jennifer A.;
    • Flaherty, Keith T.;
    • Kelley, Mark C.;
    • Misteli, Tom;
    • Chapman, Paul B.;
    • Sosman, Jeffrey A.;
    • Graeber, Thomas G.
    Publication type:
    Article
    8
    9
    10